Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma

The identification of cancer stem cells (CSCs), which are implicated in tumor initiation, progression, therapy resistance, and relapse, is of great biological and clinical relevance. In glioblastoma (GBM), this is still a challenge, as no single marker is able to universally identify populations of...

Full description

Bibliographic Details
Main Authors: Joana Vieira de Castro, Céline S. Gonçalves, Eduarda P. Martins, Irene Miranda-Lorenzo, Mariana T. Cerqueira, Adhemar Longatto-Filho, Afonso A. Pinto, Rui L. Reis, Nuno Sousa, Christopher Heeschen, Bruno M. Costa
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/4/828
_version_ 1797396364370378752
author Joana Vieira de Castro
Céline S. Gonçalves
Eduarda P. Martins
Irene Miranda-Lorenzo
Mariana T. Cerqueira
Adhemar Longatto-Filho
Afonso A. Pinto
Rui L. Reis
Nuno Sousa
Christopher Heeschen
Bruno M. Costa
author_facet Joana Vieira de Castro
Céline S. Gonçalves
Eduarda P. Martins
Irene Miranda-Lorenzo
Mariana T. Cerqueira
Adhemar Longatto-Filho
Afonso A. Pinto
Rui L. Reis
Nuno Sousa
Christopher Heeschen
Bruno M. Costa
author_sort Joana Vieira de Castro
collection DOAJ
description The identification of cancer stem cells (CSCs), which are implicated in tumor initiation, progression, therapy resistance, and relapse, is of great biological and clinical relevance. In glioblastoma (GBM), this is still a challenge, as no single marker is able to universally identify populations of GBM cancer stem cells (GSCs). Indeed, there is still controversy on whether biomarker-expressing cells fulfill the functional criteria of bona fide GSCs, despite being widely used. Here, we describe a novel subpopulation of autofluorescent (Fluo<sup>+</sup>) cells in GBM that bear all the functional characteristics of GSCs, including higher capacity to grow as neurospheres, long-term self-renewal ability, increased expression of stem cell markers, and enhanced in vivo tumorigenicity. Mechanistically, the autofluorescent phenotype is largely due to the intracellular accumulation of riboflavin, mediated by the ABC transporter ABCG2. In summary, our work identifies an intrinsic cellular autofluorescent phenotype enriched in GBM cells with functional stem cells features that can be used as a novel, simple and reliable biomarker to target these highly malignant tumors, with implications for GBM biological and clinical research.
first_indexed 2024-03-09T00:50:12Z
format Article
id doaj.art-0db4e131446f4be8b626e1245af2ed22
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T00:50:12Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-0db4e131446f4be8b626e1245af2ed222023-12-11T17:15:29ZengMDPI AGCancers2072-66942021-02-0113482810.3390/cancers13040828Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in GlioblastomaJoana Vieira de Castro0Céline S. Gonçalves1Eduarda P. Martins2Irene Miranda-Lorenzo3Mariana T. Cerqueira4Adhemar Longatto-Filho5Afonso A. Pinto6Rui L. Reis7Nuno Sousa8Christopher Heeschen9Bruno M. Costa10Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, PortugalStem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, SpainICVS/3B’s-PT Government Associate Laboratory, 4710-057/4805-017 Braga/Guimarães, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, PortugalDepartment of Neurosurgery, Hospital de Braga, 4710-243 Braga, PortugalICVS/3B’s-PT Government Associate Laboratory, 4710-057/4805-017 Braga/Guimarães, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, PortugalStem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, SpainLife and Health Sciences Research Institute (ICVS), School of Medicine, Campus Gualtar, University of Minho, 4710-057 Braga, PortugalThe identification of cancer stem cells (CSCs), which are implicated in tumor initiation, progression, therapy resistance, and relapse, is of great biological and clinical relevance. In glioblastoma (GBM), this is still a challenge, as no single marker is able to universally identify populations of GBM cancer stem cells (GSCs). Indeed, there is still controversy on whether biomarker-expressing cells fulfill the functional criteria of bona fide GSCs, despite being widely used. Here, we describe a novel subpopulation of autofluorescent (Fluo<sup>+</sup>) cells in GBM that bear all the functional characteristics of GSCs, including higher capacity to grow as neurospheres, long-term self-renewal ability, increased expression of stem cell markers, and enhanced in vivo tumorigenicity. Mechanistically, the autofluorescent phenotype is largely due to the intracellular accumulation of riboflavin, mediated by the ABC transporter ABCG2. In summary, our work identifies an intrinsic cellular autofluorescent phenotype enriched in GBM cells with functional stem cells features that can be used as a novel, simple and reliable biomarker to target these highly malignant tumors, with implications for GBM biological and clinical research.https://www.mdpi.com/2072-6694/13/4/828cancer stem cellsglioblastoma stem cellsautofluorescencebiomarkervitamin B2
spellingShingle Joana Vieira de Castro
Céline S. Gonçalves
Eduarda P. Martins
Irene Miranda-Lorenzo
Mariana T. Cerqueira
Adhemar Longatto-Filho
Afonso A. Pinto
Rui L. Reis
Nuno Sousa
Christopher Heeschen
Bruno M. Costa
Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
Cancers
cancer stem cells
glioblastoma stem cells
autofluorescence
biomarker
vitamin B2
title Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
title_full Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
title_fullStr Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
title_full_unstemmed Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
title_short Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
title_sort intracellular autofluorescence as a new biomarker for cancer stem cells in glioblastoma
topic cancer stem cells
glioblastoma stem cells
autofluorescence
biomarker
vitamin B2
url https://www.mdpi.com/2072-6694/13/4/828
work_keys_str_mv AT joanavieiradecastro intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT celinesgoncalves intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT eduardapmartins intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT irenemirandalorenzo intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT marianatcerqueira intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT adhemarlongattofilho intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT afonsoapinto intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT ruilreis intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT nunosousa intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT christopherheeschen intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma
AT brunomcosta intracellularautofluorescenceasanewbiomarkerforcancerstemcellsinglioblastoma